Ziegler Capital Management’s Viking Therapeutics VKTX Stock Holding History

Ziegler Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3.23M	Buy	+39,446	New	+$1.76M	0.12%	186

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Ziegler Capital Management's VKTX Position: Q1 2024 in Review

Ziegler Capital Management opened a new position in Viking Therapeutics (VKTX) in Q1 2024: 39,446 shares worth $3.23M. The stake represents 0.12% of the portfolio and ranks #186 among its holdings.

375 funds tracked by Wall St. Rank hold VKTX as of Q1 2024.

Ziegler Capital Management held 39,446 shares of Viking Therapeutics worth $3.23M as of Q1 2024.
Viking Therapeutics was a new Ziegler Capital Management position in Q1 2024.
Viking Therapeutics made up 0.12% of Ziegler Capital Management's portfolio in Q1 2024, its #186 holding.
375 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.